Advances in implantable cardioverter defibrillator therapy

John Rickard, Bruce L. Wilkoff

Research output: Contribution to journalArticle

Abstract

Since the first implant in 1980, implantable cardioverter defibrillator (ICD) technology has progressed rapidly. Modern ICDs have hundreds of programmable options with the general goal of preventing inappropriate shocks and providing shocks for truly life threatening symptomatic ventricular arrhythmias. New studies on ICD programming have shown the benefits of prolonged detection intervals in reaching this goal. Anti-tachycardia pacing (ATP) therapy has become an important adjunct to defibrillator shocks. Remote monitoring technologies have surfaced which have been shown to identify arrhythmias and problems with the device in an expedient fashion. The subcutaneous ICD offers the advantage of avoiding intravascular leads and their inherent risks. Lastly, the current understanding of the effects of MRI in ICD patients has advanced creating new opportunities to provide MRI safely to such patients.

Original languageEnglish (US)
Pages (from-to)291-299
Number of pages9
JournalExpert Review of Cardiovascular Therapy
Volume14
Issue number3
DOIs
StatePublished - Mar 3 2016
Externally publishedYes

Fingerprint

Implantable Defibrillators
Shock
Cardiac Arrhythmias
Technology
Defibrillators
Therapeutics
Tachycardia
Equipment and Supplies

Keywords

  • ATP
  • ICD
  • ICD programming
  • MRI and ICD
  • subcutaneous ICD

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Internal Medicine

Cite this

Advances in implantable cardioverter defibrillator therapy. / Rickard, John; Wilkoff, Bruce L.

In: Expert Review of Cardiovascular Therapy, Vol. 14, No. 3, 03.03.2016, p. 291-299.

Research output: Contribution to journalArticle

Rickard, John ; Wilkoff, Bruce L. / Advances in implantable cardioverter defibrillator therapy. In: Expert Review of Cardiovascular Therapy. 2016 ; Vol. 14, No. 3. pp. 291-299.
@article{9836304116ed453b9cdfacb17d06acee,
title = "Advances in implantable cardioverter defibrillator therapy",
abstract = "Since the first implant in 1980, implantable cardioverter defibrillator (ICD) technology has progressed rapidly. Modern ICDs have hundreds of programmable options with the general goal of preventing inappropriate shocks and providing shocks for truly life threatening symptomatic ventricular arrhythmias. New studies on ICD programming have shown the benefits of prolonged detection intervals in reaching this goal. Anti-tachycardia pacing (ATP) therapy has become an important adjunct to defibrillator shocks. Remote monitoring technologies have surfaced which have been shown to identify arrhythmias and problems with the device in an expedient fashion. The subcutaneous ICD offers the advantage of avoiding intravascular leads and their inherent risks. Lastly, the current understanding of the effects of MRI in ICD patients has advanced creating new opportunities to provide MRI safely to such patients.",
keywords = "ATP, ICD, ICD programming, MRI and ICD, subcutaneous ICD",
author = "John Rickard and Wilkoff, {Bruce L.}",
year = "2016",
month = "3",
day = "3",
doi = "10.1586/14779072.2016.1131124",
language = "English (US)",
volume = "14",
pages = "291--299",
journal = "Expert Review of Cardiovascular Therapy",
issn = "1477-9072",
publisher = "Expert Reviews Ltd.",
number = "3",

}

TY - JOUR

T1 - Advances in implantable cardioverter defibrillator therapy

AU - Rickard, John

AU - Wilkoff, Bruce L.

PY - 2016/3/3

Y1 - 2016/3/3

N2 - Since the first implant in 1980, implantable cardioverter defibrillator (ICD) technology has progressed rapidly. Modern ICDs have hundreds of programmable options with the general goal of preventing inappropriate shocks and providing shocks for truly life threatening symptomatic ventricular arrhythmias. New studies on ICD programming have shown the benefits of prolonged detection intervals in reaching this goal. Anti-tachycardia pacing (ATP) therapy has become an important adjunct to defibrillator shocks. Remote monitoring technologies have surfaced which have been shown to identify arrhythmias and problems with the device in an expedient fashion. The subcutaneous ICD offers the advantage of avoiding intravascular leads and their inherent risks. Lastly, the current understanding of the effects of MRI in ICD patients has advanced creating new opportunities to provide MRI safely to such patients.

AB - Since the first implant in 1980, implantable cardioverter defibrillator (ICD) technology has progressed rapidly. Modern ICDs have hundreds of programmable options with the general goal of preventing inappropriate shocks and providing shocks for truly life threatening symptomatic ventricular arrhythmias. New studies on ICD programming have shown the benefits of prolonged detection intervals in reaching this goal. Anti-tachycardia pacing (ATP) therapy has become an important adjunct to defibrillator shocks. Remote monitoring technologies have surfaced which have been shown to identify arrhythmias and problems with the device in an expedient fashion. The subcutaneous ICD offers the advantage of avoiding intravascular leads and their inherent risks. Lastly, the current understanding of the effects of MRI in ICD patients has advanced creating new opportunities to provide MRI safely to such patients.

KW - ATP

KW - ICD

KW - ICD programming

KW - MRI and ICD

KW - subcutaneous ICD

UR - http://www.scopus.com/inward/record.url?scp=84959110279&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959110279&partnerID=8YFLogxK

U2 - 10.1586/14779072.2016.1131124

DO - 10.1586/14779072.2016.1131124

M3 - Article

VL - 14

SP - 291

EP - 299

JO - Expert Review of Cardiovascular Therapy

JF - Expert Review of Cardiovascular Therapy

SN - 1477-9072

IS - 3

ER -